论文部分内容阅读
目的:分析研究左氧氟沙星结合头胞哌酮舒巴坦治疗老年肺炎患者的临床效果。方法:选取2011年9月-2014年9月在我院接收的老年肺炎患者一共有260例,随机分为观察组、对照组,对照组对病人采取头孢哌酮舒巴坦治疗,观察组在此基础采取左氧氟沙星治疗,对两组患者的临床疗效和不良反应给予对比。结果:观察组患者的临床治疗总体有效率显著优于对照组(P<0.05);观察组患者发生不良反应的几率明显低于对照组(P<0.05)。结论:老年肺炎患者采取左氧氟沙星结合头胞哌酮舒巴坦共同治疗,可以取得显著的治疗效果,并且不良反应较低,具有临床推广价值。
Objective: To analyze the clinical effect of levofloxacin combined with ceftazidipatam in elderly patients with pneumonia. Methods: A total of 260 elderly patients with pneumonia received in our hospital from September 2011 to September 2014 were randomly divided into observation group, control group and control group. Patients in observation group were treated with cefoperazone sulbactam This basis to take levofloxacin treatment, the clinical efficacy and adverse reactions in both groups to give comparison. Results: The overall effective rate of clinical treatment in observation group was significantly better than that in control group (P <0.05). The incidence of adverse reactions in observation group was significantly lower than that in control group (P <0.05). CONCLUSION: The combination of levofloxacin and cefoperazone-sulbactam for elderly patients with pneumonia can achieve significant therapeutic effect with low adverse reactions and is of clinical promotion value.